RNAC
Cartesian Therapeutics, Inc. Common Stock
$7.50
4.30%
+0.31
Notify me if price changes either direction
Buy RNAC stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
221.5M
Enterprise value
105.1M
Trailing PE
1.9756098
Forward PE
-2.6902986
PEG Ratio
0.017223264923077
Enterprise to EBITDA
-1.182
Enterprise to revenue
59.186
Price to book MRQ
-1.3725107729648
Price to sales TTM
119.346886
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
1.8M
EBITDA
-88897000
Diluted EPS TTM
-5.8
Total Cash (MRQ)
118.6M
Current ratio (MRQ)
7.654
Operating Cash Flow (TTM)
-72968000
RNAC trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
